Ceftriaxone Inj. 125mg/250mg/500mg/1gm /2gm

What is Ceftriaxone Inj. 125mg/250mg/500mg/1gm /2gm?

Ceftriaxone Inj. is a cephalosporin antibiotic presented as a dry powder injection. It is used to treat certain bacterial infections caused by susceptible organisms. Its use depends on the infection, bacterial susceptibility, patient-specific factors and applicable prescribing information. The injection must be prepared and administered by qualified healthcare professionals according to the approved product instructions.

Uses / Indications

Ceftriaxone is a third-generation cephalosporin antibiotic used for certain bacterial infections when clinically indicated. Depending on the approved product information, its uses may include:

• Certain respiratory tract infections.

• Selected urinary tract infections.

• Skin and soft-tissue infections.

• Intra-abdominal infections.

• Bone and joint infections.

• Certain cases of bacterial meningitis.

• Septicaemia and other serious bacterial infections.

• Selected infections requiring surgical prophylaxis, where indicated.

The appropriate indication depends on the causative organism, susceptibility results, clinical assessment and local treatment guidelines. Ceftriaxone is not effective against viral infections such as the common cold or influenza.

5. Benefits

• Contains ceftriaxone, an established antibacterial active ingredient.

• Available in multiple listed strengths: 125mg, 250mg, 500mg, 1gm and 2gm.

• Dry powder injection presentation for preparation according to approved instructions.

• Intended for use in appropriate clinical settings under professional supervision.

• Pharmaceutical sourcing and export enquiries can be directed to Kelar Pharmachem India, subject to product availability and confirmation.

6. Side Effects

Common Side Effects

• Diarrhoea or loose stools.

• Nausea or vomiting.

• Injection-site pain or tenderness.

• Skin rash or itching.

• Changes in liver enzyme results.

Less Common or Serious Side Effects

• Severe allergic reactions, including anaphylaxis.

• Severe or persistent diarrhoea associated with antibiotic treatment.

• Changes in blood cell counts.

• Biliary sludge or gallbladder-related complications.

• Kidney-related complications or urinary precipitation in susceptible patients.

• Serious skin reactions, which require urgent assessment.

Seek immediate medical attention if severe allergic symptoms, breathing difficulties, facial swelling or serious skin reactions occur.

7. How Does It Work?

Ceftriaxone belongs to the beta-lactam group of antibiotics. It inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins, interfering with the formation of a functional cell wall and causing susceptible bacteria to die. Its activity depends on the organism’s susceptibility. It does not treat viral infections.

8. Dosage Guidelines

The appropriate dose and treatment duration depend on the infection being treated, its severity, the patient’s age and weight, kidney and liver function where relevant, and the approved prescribing information.

• Use only the dose prescribed by a qualified healthcare professional.

• Follow the approved instructions for the intended route of administration.

• Reconstitution, diluent selection and administration must follow the specific product instructions.

• Special assessment may be necessary for neonates and patients with significant renal or hepatic impairment.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

9. When Not to Use

Ceftriaxone should not be used in patients with a known serious hypersensitivity to ceftriaxone or relevant cephalosporin antibiotics.

• Inform the healthcare professional about previous allergic reactions to penicillins or other beta-lactam antibiotics.

• Ceftriaxone has specific restrictions for certain neonates, including those with relevant hyperbilirubinaemia risks or those requiring intravenous calcium-containing solutions. These restrictions must be checked against the approved product information.

• Other contraindications may depend on the specific product and patient circumstances.

A healthcare professional should review the patient’s allergy history and relevant clinical factors before treatment.

10. Drug / Product Interactions

Potentially important interactions and precautions include:

• Calcium-containing intravenous solutions: Particular restrictions apply to ceftriaxone in neonates; compatibility and administration precautions must be followed.

• Anticoagulants: Clotting parameters may require monitoring in selected patients.

• Other antibiotics: Concurrent use should be based on a clinical indication rather than assumed to improve treatment.

• Medicines affecting kidney function: Review the complete treatment regimen where renal risks are relevant.

Do not mix ceftriaxone with another medicine in the same syringe or infusion line unless compatibility is confirmed by authoritative product-specific guidance.

11. Safety Advice

• Use only under appropriate medical supervision.

• Check the patient’s allergy history before administration.

• Verify the prescribed strength, dose and route.

• Follow the approved reconstitution and administration instructions.

• Monitor for serious allergic reactions and significant gastrointestinal symptoms.

• Use antibiotics only for appropriate bacterial indications to help limit antimicrobial resistance.

• Inform the healthcare professional about pregnancy, breastfeeding, neonatal status or significant kidney or liver disease.

12. General Instructions

• Check the product name, strength, batch number and expiry date before use.

• Inspect the vial and container closure for damage.

• Use appropriate aseptic handling practices.

• Follow the product-specific instructions for preparation and administration.

• Do not use a compromised container or a product that fails applicable quality checks.

• Follow the approved instructions for handling and use after reconstitution.

• Dispose of unused medicine and clinical waste according to applicable procedures.

Do not assume that the same diluent, reconstitution volume or post-reconstitution stability applies to every ceftriaxone presentation.

13. Special Dietary / Lifestyle Tips

No universal dietary restriction applies to all ceftriaxone injection presentations.

• Follow the treatment plan provided by the healthcare professional.

• Complete the prescribed course as directed.

• Report persistent diarrhoea or unexpected symptoms.

• Do not share antibiotics or use leftover antibiotics for another illness.

14. Comparison with Other Treatments

Ceftriaxone is not universally preferable to other antibiotics. Treatment selection should consider the infection site, suspected or confirmed pathogen, susceptibility results, patient-specific factors and local guidelines.

15. Precautions & Warnings

• Hypersensitivity: Assess previous reactions to cephalosporins and other beta-lactam antibiotics.

• Neonatal use: Observe specific restrictions involving hyperbilirubinaemia and intravenous calcium-containing solutions.

• Gastrointestinal effects: Severe or persistent diarrhoea requires medical evaluation.

• Biliary complications: Consider relevant symptoms and patient risk factors.

• Renal and hepatic conditions: Assess whether monitoring or treatment adjustments are needed.

• Antimicrobial resistance: Avoid unnecessary antibiotic use.

• Pregnancy and breastfeeding: Assess treatment suitability according to the approved product information and clinical circumstances.

16. Can I Use It With Other Medicines?

Ceftriaxone may be prescribed alongside other medicines when clinically appropriate, but this requires professional assessment.

Tell the healthcare professional about all prescription medicines, non-prescription products and supplements being used. Particular attention is needed for calcium-containing intravenous solutions, anticoagulants and any medicines that may affect kidney function or require additional monitoring.

Physical compatibility when mixing medicines is different from an interaction after administration. Always follow the product-specific compatibility instructions.

17. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Follow the specific instructions for unopened vials and for solutions after reconstitution. Do not assume a universal storage temperature or post-reconstitution shelf life.

18. Frequently Asked Questions (FAQs)

1. What is Ceftriaxone Inj. used for?

It is a cephalosporin antibiotic used to treat certain susceptible bacterial infections when clinically indicated.

2. Which active ingredient does the product contain?

The active ingredient is ceftriaxone.

3. Which strengths are listed?

The supplied strengths are 125mg, 250mg, 500mg, 1gm and 2gm. Availability of individual strengths should be confirmed with the supplier.

4. How is ceftriaxone injection prepared?

A qualified healthcare professional must prepare it according to the approved product-specific instructions, including the correct diluent and administration method.

5. Can ceftriaxone be used in patients with a penicillin allergy?

A history of penicillin allergy requires individual assessment. Cross-reactivity risks depend on the nature of the allergy and the medicines involved.

6. What precautions apply to ceftriaxone in neonates?

Specific restrictions apply to certain neonates, including those with hyperbilirubinaemia and those requiring intravenous calcium-containing solutions. The approved prescribing information must be consulted.

7. How should ceftriaxone injection be stored?

Follow the manufacturer’s approved labelling and package insert for the exact storage conditions and handling after reconstitution.

8. Is ceftriaxone injection available for pharmaceutical export?

Kelar Pharmachem India accepts pharmaceutical sourcing and export enquiries. Product availability, destination-market requirements and supporting documentation must be confirmed individually.